Abstract:Objective To explore the influence of disturbed glucose and lipid metabolism on the pregnant outcomes in patients with preeclampsia-eclampsia (PE-E) and the risk factors for poor prognosis of preeclampsia.Methods The expression of peroxisome proliferation-activated receptorγ (PPAR-γ) mRNA was detected by reverse transcription PCR,and the levels of insulin sensitive index (ISI),homeostasis model assessment-insulin resistance index (HOMA-IR) and other laboratory indexes were tested in 51 PE-E patients (PE-E group) and 40 healthy pregnant women (control group).The maternal complications and neonatal outcomes were recorded to analyze the influencing factors for PE-E and its adverse outcomes.Results The ISI (-3.71 ± 0.92),hematocrit ((0.35 ± 0.05) ％) and platelet count ((184.14 ± 76.83) × 109/L) in PE-E group were significantly lower than those in control group (-2.98 ±0.55,(0.37±0.03)％,(216.63±54.05) × 109/L) (P＜0.05),and HOMA-IR (1.61(1.07,3.65)),total cholesterol ((6.67±1.27) mmol/L),triacylglycerol ((4.74 ± 2.46) mmol/L),glutamic pyruvic transaminase (23.10 (15.90,37.40) u/L),glutamic oxaloacetic transaminase (28.50(23.20,48.10) u/L),lactate dehydrogenase ((506.37±358.58) u/L),creatinine ((71.71±58.58) mmol/L) and uric acid ((429.6±109.17) mmol/L) in PE-E group were significantly higher than those in control group (0.76(0.61,1.37),(6.07±1.94) mmol/L,(4.02±1.75) mmol/L,12.50(11.00,16.75) u/L,19.00(16.00,21.75) u/L,(180.48±31.56) u/L,(44.78±8.67) mmol/L,(324.8±79.69) mmol/L) (P＜ 0.05).There was no significant difference in PPAR-γ mRNA between PE-E group (0.53 ± 0.28) and control group (0.41±0.31) (P＞0.05).The elevated total cholesterol level (OR=2.003,95％CI:1.156 to 3.469,P=0.013) and PPAR-γ mRNA (OR=13.285,95％CI:1.743 to 101.271,P=0.013) were the risk factors for PE E,and the elevated ISI (OR=0.290,95％CI:0.129 to 0.653,P=0.003) was a protective factor for PE-E as well as for severe perinatal complications (OR=0.021,95％CI:0.003 to 0.155,P＜0.001) and fetal growth retardation (OR=0.058,95％CI:0.003 to 0.966,P=0.047).The high body mass index before pregnancy was a risk factor for fetal distress (OR=1.701,95％CI:1.194 to 2.423,P 0.003),negatively correlated with neonatal Apgar score (β=-0.168,95％CI:-0.265 to-0.072,P=0.001) and delivering gestational age (β=0.221,95％CI:-0.406 to-0.036,P=0.020).Conclusion Insulin resistance is a risk factor for PE-E,severe perinatal complications and fetal growth retardation.High levels of total cholesterol and PPAR-γ mRNA are the risk factors for PE-E.To reduce the body mass before pregnancy contributes to reducing fetal distress,neonatal asphysia and premature delivery.

Relationship Between Expressions of Á2-Hs-glycoprotein Gene Mrna and Protein in Placenta and Insulin Resistance in Preeclampsia Patients

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

[Relationship Between Serum and Placental Interleukin-18 Levels and Preeclampsia].

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Study on the correlation between expression level of A-FABP and insulin-resistance in the patients with preeclampsia

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Relationship Between Expression of Vimentin, Type IV Collagen and Fibronectin in Human Placenta and Pregnancy Induced Hypertension

Imbalance of Serum T Helper 1- and 2-Type Cytokines in Preeclampsia and Gestational Hypertension

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Placental Expression of Lipoprotein Lipase and Endothelial Lipase in Women with Severe Preeclampsia

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Expressions of Irisin and Urotensin II and Their Relationships with Blood Pressure in Patients with Preeclampsia

Methylation Levels at Igf2 and Gnas Dmrs in Infants Born to Preeclamptic Pregnancies

Expression of Hypoxia-Inducible Factor Prolyl 4-Hydroxylase in Placentas of Normal Pregnant Women and Patients with Pre-Eclampsia

Expression of Various Subtypes of HLA-G Mrna in Placentas of Pregnant Women Complicated with Severe Preeclampsia

Study on the expressions of PHD and HIF in placentas from normal pregnant women and patients with preeclampsia.

Placental expressions of Anti-Mullerian hormone/Receptor, vascular endothelial growth factor and related microRNAs in patients with preeclampsia: a case control study

Study on the Relation Between Concentration of Circulating Non-Host Fetal DNA in Pregnant Women and Pre-Eclampsia

Correlation between pregnant outcome and disturbed glucose-lipid metabolism in preeclampsia-eclampsia patients